Archives in Cancer Research

  • ISSN: 2254-6081
  • Journal h-index: 12
  • Journal CiteScore: 2.71
  • Journal Impact Factor: 2.30
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Google Scholar
  • Secret Search Engine Labs
Share This Page
Recommended Webinars & Conferences

13th World Congress on Breast Cancer Research & Therapies

Amsterdam, Netherlands

10th International Summit on Cancer Research and Diagnosis

Amsterdam, Netherlands


"Drop Recurrence" External Genitalia Recurrence in Carcinoma Cervix after Previous Surgery

Kapil Dev, Venkateshaiah R Pallavi  and Uttam D Bafna

Cervical cancer is the most common cancer in women in India and diagnosed new cases around 1,32,000 and 74,000 deaths annually. Although, a progress in the management of cervical cancer has been accomplished over the past 5-6 decades, including introduction of PAP smear into screening as well as surveillance and addition of systemic platinum based chemotherapy to radiation therapy with proved definite benefits, the rate of recurrence in optimally treated cervical cancer is still significant. Up to 10% to 25% women with cervical cancer stage IB-IIA without lymph node involvement experience a recurrence, which is higher among patients with advance stages with lymph node involvement and locally advanced disease, and ranges up to 70%. The majority of the recurrences in cervical cancer are pelvic failure in comparison to distant recurrence, irrespective of the stage at diagnosis and prior treatment taken.